Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Cymabay Therapeutics Inc
About CBAY
CymaBay Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies for patients with liver and other chronic diseases. The Company's lead product candidate, seladelpar (MBX-8025), is a potent and selective agonist of peroxisome proliferator-activated receptor delta (PPARd), a nuclear receptor that regulates genes directly or indirectly involved in the synthesis of bile acids/sterols, metabolism of lipids and glucose, inflammation and fibrosis. The Company is focused on developing seladelpar for the treatment of primary biliary cholangitis (PBC), an autoimmune disease that causes progressive destruction of the bile ducts in the liver resulting in impaired bile flow (cholestasis) and inflammation.
Find out what a historical investment in Cymabay Therapeutics Inc would be worth today using our CBAY stock calculator.
Market Capitalisation
-
Price-earnings ratio
-
Dividend yield
-
Volume
-
High today
-
Low today
-
Open price
-
52-week high
-
52-week low
-
Ready to start your investing journey with Stake?
Open an accountHow do I buy CBAY shares in Australia?
Buying CBAY shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Cymabay Therapeutics Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in CBAY
What is the ticker symbol of Cymabay Therapeutics Inc?
The ticker symbol for Cymabay Therapeutics Inc is CBAY.
How much is one share of CBAY?
One share of CBAY is valued at $32.48 as of 17 May 2026.
What is the market capitalisation of Cymabay Therapeutics Inc CBAY?
As of 17 May 2026 Cymabay Therapeutics Inc has a market cap of -.
What is the 52-week high for Cymabay Therapeutics Inc stock?
The Cymabay Therapeutics Inc 52-week high stock price is $NaN.
What is the 52-week low for Cymabay Therapeutics Inc stock?
The Cymabay Therapeutics Inc 52-week low stock price is $NaN.
Can I buy CBAY shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy CBAY shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in CBAY on Stake
- Buy CBAY from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of CBAY from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
CBAY related stocks